Switzerland / Germany / Turkey / United States / Croatia / Iceland / Canada / Australia / Korea / Israel / New Zealand / /
Facility
Tel Aviv University / ITFoM Consortium Max Planck Institute / Free University of Amsterdam/Univ. / Max Planck Institute / /
IndustryTerm
software engineering / mathematical tools / personalised medicine solutions / analytical technologies / Cancer therapies / treatment of cancer / functional and regulatory networks / data gathering infrastructure / biological systems / technology development / healthcare / healthcare systems •use cases / imaging / /
MedicalCondition
uveal melanoma / tumor / Cancer / disease / metabolic and rare diseases / e.g. cancer / patient's tumor / heart disease / melanomas / cutaneous and uveal melanomas / multifactorial disease / diseases / each tumor / key tumor / metastatic melanoma / /
MedicalTreatment
Cancer therapies / /
Organization
Charité Comprehensive Cancer Center / University of Amsterdam / European Commission / Tel Aviv University / ITFoM Consortium Max Planck Institute for Molecular Genetics / Max Planck Institute for Molecular Genetics / /
Person
Kurt Zatloukal / Markus Pasterk / Ewan Birney / Hans Westerhoff / Hans Lehrach / Oskar Mencer / Nora Benhabiles / /
Key Technology for Molecular Models within the European Initiative IT Future of Medicine (ITFoM) Sudbrak R, Regierer B, Zazzu V, and Lehrach H on behalf of the ITFoM Consortium Max Planck Institute for Molecular Genetics